A phase II study of single-agent OSI-7904L in patients with locally advanced or metastatic squamous cell carcinoma of the head and neck who have failed first-line therapy
Phase of Trial: Phase II
Latest Information Update: 13 Mar 2007
At a glance
- Drugs OVI 237 (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 05 Nov 2005 New trial record.